1.
Case Rep Oncol
; 10(2): 534-541, 2017.
Artículo
en Inglés
| MEDLINE
| ID: mdl-28690529
RESUMEN
Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we present a patient who was heavily pretreated for CLL, including allogeneic stem cell transplant, and progressed to RT. She had a mixed response to multi-agent chemotherapy and was started on ibrutinib. She had a complete response for 16 months on single-agent ibrutinib with minimal toxicity.
2.
J Clin Oncol
; 28(22): e380-1, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20458054